Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Thymine (CAS 65-71-4) Market by Type (Thymine (97%), Thymine (99%), Other), By Application (Pharmaceutical Intermediates, Bioengineering, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Thymine (CAS 65-71-4) Market by Type (Thymine (97%), Thymine (99%), Other), By Application (Pharmaceutical Intermediates, Bioengineering, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 144475 3300 Chemical & Material 377 230 Pages 4.6 (39)
                                          

The global thymine market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of the market can be attributed to the increasing demand for pharmaceutical intermediates and bioengineering applications in various industries such as food & beverage, cosmetics, and healthcare. Thymine (97%) segment is expected to account for a significant share of the global thymine market during the forecast period owing to its high demand in pharmaceutical intermediates application. Thymine (99%) segment is also expected to witness significant growth due to its high demand in bioengineering application which includes DNA sequencing and gene editing among others. North America accounted for a major share of the global thymine market owing to its presence in developed economies such as US, Canada, and Mexico among others which are witnessing an increase in research activities related with biotechnology and pharmaceuticals sectors that are driving up demand for thymine products across these regions.

Some Of The Growth Factors Of This Market:

  1. Thymine is a nucleobase that is found in DNA and RNA.
  2. Thymine is an essential component of DNA, which makes up the genetic code for all living organisms on Earth.
  3. Thymine can be used to make thyminesulfonic acid, which has many industrial applications such as in the production of polymers and dyes, as well as in the manufacture of pharmaceuticals and agricultural chemicals.

Industry Growth Insights published a new data on “Thymine (CAS 65-71-4) Market”. The research report is titled “Thymine (CAS 65-71-4) Market research by Types (Thymine (97%), Thymine (99%), Other), By Applications (Pharmaceutical Intermediates, Bioengineering, Other), By Players/Companies Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Thymine (CAS 65-71-4) Market Research Report

By Type

Thymine (97%), Thymine (99%), Other

By Application

Pharmaceutical Intermediates, Bioengineering, Other

By Companies

Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

230

Number of Tables & Figures

161

Customization Available

Yes, the report can be customized as per your need.


Global Thymine (CAS 65-71-4) Industry Outlook


Global Thymine (CAS 65-71-4) Market Report Segments:

The global Thymine (CAS 65-71-4) market is segmented on the basis of:

Types

Thymine (97%), Thymine (99%), Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical Intermediates, Bioengineering, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Sintofarm S.P.A.
  2. Yulchon Pharmaceutical
  3. 3B Pharmachem
  4. Sigma-Aldrich
  5. Morre-Tec Industries
  6. Cambridge Isotope
  7. George Uhe Company
  8. Degussa Fine Chemicals
  9. Taiyuan RHF
  10. Sarepta Therapeutics
  11. Zhangjiagang Aihua Chemical
  12. Wuhan Yuancheng Gongchuang Technology

Global Thymine (CAS 65-71-4) Market Overview


Highlights of The Thymine (CAS 65-71-4) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Thymine (97%)
    2. Thymine (99%)
    3. Other
  1. By Application:

    1. Pharmaceutical Intermediates
    2. Bioengineering
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Thymine (CAS 65-71-4) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Thymine (CAS 65-71-4) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Thymine is a chemical element with the symbol T and atomic number 66. Thymine is a radioactive element that occurs naturally in the environment. It is also produced by the irradiation of other elements. Thymine is used in nuclear reactors to create energy.

Some of the major companies in the thymine (cas 65-71-4) market are Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology.

The thymine (cas 65-71-4) market is expected to grow at a compound annual growth rate of 3.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Thymine (CAS 65-71-4) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Thymine (CAS 65-71-4) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Thymine (CAS 65-71-4) Market - Supply Chain
   4.5. Global Thymine (CAS 65-71-4) Market Forecast
      4.5.1. Thymine (CAS 65-71-4) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Thymine (CAS 65-71-4) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Thymine (CAS 65-71-4) Market Absolute $ Opportunity

5. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      5.3.1. Thymine (97%)
      5.3.2. Thymine (99%)
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      6.3.1. Pharmaceutical Intermediates
      6.3.2. Bioengineering
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026

9. North America Thymine (CAS 65-71-4) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      9.4.1. Pharmaceutical Intermediates
      9.4.2. Bioengineering
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      9.7.1. Thymine (97%)
      9.7.2. Thymine (99%)
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026

10. Latin America Thymine (CAS 65-71-4) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      10.4.1. Pharmaceutical Intermediates
      10.4.2. Bioengineering
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      10.7.1. Thymine (97%)
      10.7.2. Thymine (99%)
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026

11. Europe Thymine (CAS 65-71-4) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      11.4.1. Pharmaceutical Intermediates
      11.4.2. Bioengineering
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      11.7.1. Thymine (97%)
      11.7.2. Thymine (99%)
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Thymine (CAS 65-71-4) Demand Share, 2019-2026

12. Asia Pacific Thymine (CAS 65-71-4) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      12.4.1. Pharmaceutical Intermediates
      12.4.2. Bioengineering
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      12.7.1. Thymine (97%)
      12.7.2. Thymine (99%)
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Thymine (CAS 65-71-4) Demand Share, 2019-2026

13. Middle East & Africa Thymine (CAS 65-71-4) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
      13.4.1. Pharmaceutical Intermediates
      13.4.2. Bioengineering
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
      13.7.1. Thymine (97%)
      13.7.2. Thymine (99%)
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Thymine (CAS 65-71-4) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Thymine (CAS 65-71-4) Market: Market Share Analysis
   14.2. Thymine (CAS 65-71-4) Distributors and Customers
   14.3. Thymine (CAS 65-71-4) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Sintofarm S.P.A.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Yulchon Pharmaceutical
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. 3B Pharmachem
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Sigma-Aldrich
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Morre-Tec Industries
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Cambridge Isotope
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. George Uhe Company
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Degussa Fine Chemicals
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Taiyuan RHF
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Sarepta Therapeutics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Zhangjiagang Aihua Chemical
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Wuhan Yuancheng Gongchuang Technology
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us